FHTX
Foghorn Therapeutics Inc
$5.78
Earnings Summary
Revenue | $5.77Mn |
Net Profits | $-24.11Mn |
Net Profit Margins | -417.85% |
Highlights
Foghorn Therapeutics Inc’s revenue jumped 37.88% since last year same period to $5.77Mn in the Q4 2023. On a quarterly growth basis, Foghorn Therapeutics Inc has generated -66.99% fall in its revenue since last 3-months.
Foghorn Therapeutics Inc’s net profit jumped 29.38% since last year same period to $-24.11Mn in the Q4 2023. On a quarterly growth basis, Foghorn Therapeutics Inc has generated -68.04% fall in its net profits since last 3-months.
Foghorn Therapeutics Inc’s net profit margin jumped 48.78% since last year same period to -417.85% in the Q4 2023. On a quarterly growth basis, Foghorn Therapeutics Inc has generated -409.11% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Foghorn Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.63 |
EPS Estimate Current Year | -0.63 |
Highlights
Foghorn Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.63 - a 17.11% jump from last quarter’s estimates.
Foghorn Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.63.
Key Ratios
Key ratios of the Foghorn Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.57 |
Highlights
Foghorn Therapeutics Inc’s earning per share (EPS) jumped 17.39% since last year same period to -0.57 in the Q4 2023. This indicates that the Foghorn Therapeutics Inc has generated 17.39% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-03-07 | -0.76 | -0.57 | 25% |
2023-08-04 | -0.73 | -0.7 | 4.11% |
2023-05-08 | -0.72 | -0.73 | -1.39% |
2023-11-02 | -0.75 | -0.34 | 54.67% |
₹0 US Stocks a/c Opening Fee